What Is 19-Nortestosterone pelargonate

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 14, 2026

Quick Answer: 19-Nortestosterone pelargonate is a synthetic anabolic steroid ester derived from nandrolone, developed in the 1950s but never marketed. It has a half-life of approximately 4–5 days and was studied for its tissue-building properties.

Key Facts

19-Nortestosterone pelargonate is a derivative of nandrolone, first synthesized in the 1950s
It has an esterified form with pelargonic acid, extending its half-life to ~4–5 days
The compound was never commercialized despite preclinical studies
It exhibits anabolic effects with reduced androgenic activity compared to testosterone
Research interest peaked in the 1960s before regulatory scrutiny increased

Overview

19-Nortestosterone pelargonate is a synthetic organic compound belonging to the class of 19-nortestosterone derivatives, commonly known as nandrolone analogs. It functions as a long-acting prodrug, releasing active nandrolone upon metabolic breakdown in the body.

Developed during the mid-20th century, this compound was studied for its potential in treating muscle-wasting conditions and osteoporosis. Despite promising early pharmacological profiles, it never advanced to clinical use or commercial distribution.

Nandrolone base structure: The molecule is derived from testosterone but lacks a methyl group at the 19th carbon position, reducing androgenic side effects while maintaining anabolic potency.
Pelargonic acid esterification: The addition of pelargonic acid (nonanoic acid) increases lipid solubility, allowing for slower release from intramuscular injection sites.
Half-life duration: Studies estimate a plasma half-life of 4–5 days after intramuscular administration, making it suitable for weekly dosing regimens.
Historical development: First synthesized in 1956 by researchers at Schering AG, it was part of a broader effort to optimize anabolic steroid profiles.
Metabolic pathway: Once hydrolyzed, it converts to nandrolone, which binds to androgen receptors with affinity 20% higher than testosterone in muscle tissue.

How It Works

19-Nortestosterone pelargonate functions as a depot anabolic steroid, delivering sustained levels of active hormone through gradual enzymatic cleavage of its ester bond.

Prodrug activation: After injection, esterases in the liver and plasma cleave the pelargonate group, releasing free nandrolone over 3–5 days, enabling prolonged anabolic activity.
Androgen receptor binding: The liberated nandrolone binds to intracellular androgen receptors in skeletal muscle, promoting protein synthesis rates by up to 30% in preclinical models.
Reduced aromatization: Unlike testosterone, 19-nortestosterone derivatives undergo minimal conversion to estrogens, lowering risk of gynecomastia and water retention.
Glucocorticoid antagonism: Nandrolone exhibits anti-catabolic effects by opposing cortisol activity, preserving lean mass during caloric deficit or illness.
Hepatic metabolism: The compound is metabolized primarily in the liver via CYP3A4 enzymes, with a bioavailability of 85–90% following intramuscular delivery.
Excretion timeline: Metabolites are detectable in urine for up to 14 days, a factor influencing its classification in anti-doping regulations.

Comparison at a Glance

Below is a comparative analysis of 19-Nortestosterone pelargonate and related anabolic agents based on pharmacokinetics and potency.

Compound	Ester Chain	Half-Life (Days)	Anabolic Rating	Androgenic Rating
19-Nortestosterone pelargonate	Pelargonic acid	4–5	125	37
Nandrolone decanoate	Decanoic acid	6–8	125	37
Testosterone propionate	Propionic acid	0.8–1	100	100
Methandrostenolone	Oral, unesterified	0.2	130	60
Trenbolone hexahydrobenzylcarbonate	Hexahydrobenzylcarbonate	2–3	500	500

This table illustrates that 19-Nortestosterone pelargonate occupies a middle ground in release duration and receptor activity. While less potent than trenbolone, it offers a more favorable safety profile. Its lack of commercialization contrasts with nandrolone decanoate, which became widely used in veterinary and human medicine.

Why It Matters

Though never marketed, 19-Nortestosterone pelargonate contributed to the development of long-acting anabolic agents and informed later drug design strategies in endocrinology.

Pharmacological blueprint: Its esterification model influenced the creation of nandrolone decanoate, approved in 1960 for treating breast cancer and anemia.
Anti-catabolic therapy: Early trials suggested efficacy in reversing muscle atrophy in post-surgical and elderly patients.
Doping control significance: As a precursor to detectable nandrolone metabolites, it remains on the WADA Prohibited List since 2004.
Research utility: Used in laboratory studies to isolate effects of sustained nandrolone exposure without frequent dosing.
Regulatory impact: Its development coincided with the 1960 Controlled Substances Act, shaping future steroid regulation.
Legacy in sports science: Athletes in the 1970s reportedly experimented with unapproved esters, including pelargonate variants, for performance enhancement.

While overshadowed by more successful analogs, 19-Nortestosterone pelargonate remains a footnote in steroid pharmacology with enduring relevance in forensic and medical research.